LT3501534T - Vakcinos kompozicijos, apimančios mutuotą, faktorių h surišantį baltymą - Google Patents

Vakcinos kompozicijos, apimančios mutuotą, faktorių h surišantį baltymą

Info

Publication number
LT3501534T
LT3501534T LTEP18209661.0T LT18209661T LT3501534T LT 3501534 T LT3501534 T LT 3501534T LT 18209661 T LT18209661 T LT 18209661T LT 3501534 T LT3501534 T LT 3501534T
Authority
LT
Lithuania
Prior art keywords
binding protein
vaccine compositions
mutated factor
mutated
factor
Prior art date
Application number
LTEP18209661.0T
Other languages
English (en)
Lithuanian (lt)
Inventor
Rachel Exley
Christoph Tang
Susan Lea
Original Assignee
Ip2Ipo Innovations Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ip2Ipo Innovations Limited filed Critical Ip2Ipo Innovations Limited
Publication of LT3501534T publication Critical patent/LT3501534T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LTEP18209661.0T 2008-10-25 2009-10-26 Vakcinos kompozicijos, apimančios mutuotą, faktorių h surišantį baltymą LT3501534T (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0819633.9A GB0819633D0 (en) 2008-10-25 2008-10-25 Composition

Publications (1)

Publication Number Publication Date
LT3501534T true LT3501534T (lt) 2024-03-12

Family

ID=40133849

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP18209661.0T LT3501534T (lt) 2008-10-25 2009-10-26 Vakcinos kompozicijos, apimančios mutuotą, faktorių h surišantį baltymą

Country Status (23)

Country Link
US (1) US20120052092A1 (cg-RX-API-DMAC7.html)
EP (2) EP3501534B1 (cg-RX-API-DMAC7.html)
JP (2) JP5676458B2 (cg-RX-API-DMAC7.html)
KR (3) KR20170000390A (cg-RX-API-DMAC7.html)
CN (2) CN105412920A (cg-RX-API-DMAC7.html)
AU (1) AU2009306114B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0919926A2 (cg-RX-API-DMAC7.html)
CA (1) CA2741619A1 (cg-RX-API-DMAC7.html)
CO (1) CO6382140A2 (cg-RX-API-DMAC7.html)
DK (1) DK3501534T5 (cg-RX-API-DMAC7.html)
ES (1) ES2970878T3 (cg-RX-API-DMAC7.html)
FI (1) FI3501534T3 (cg-RX-API-DMAC7.html)
GB (1) GB0819633D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20240226T1 (cg-RX-API-DMAC7.html)
HU (1) HUE065348T2 (cg-RX-API-DMAC7.html)
LT (1) LT3501534T (cg-RX-API-DMAC7.html)
MX (1) MX2011004322A (cg-RX-API-DMAC7.html)
NZ (2) NZ601538A (cg-RX-API-DMAC7.html)
PL (1) PL3501534T3 (cg-RX-API-DMAC7.html)
PT (1) PT3501534T (cg-RX-API-DMAC7.html)
RU (1) RU2559528C2 (cg-RX-API-DMAC7.html)
SI (1) SI3501534T1 (cg-RX-API-DMAC7.html)
WO (1) WO2010046715A1 (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX343752B (es) 1998-05-01 2016-11-22 Novartis Vaccines & Diagnostics Inc Antigenos de neisseria meningitidis y composiciones que los contienen.
WO2000071725A2 (en) 1999-05-19 2000-11-30 Chiron S.P.A. Combination neisserial compositions
PT2275551E (pt) 1999-10-29 2015-06-29 Novartis Vaccines & Diagnostic Péptidos antigénicos de neisseria
ATE503837T1 (de) 2000-02-28 2011-04-15 Novartis Vaccines & Diagnostic Hybride expression neisserscher proteine
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
ATE492288T1 (de) 2002-10-11 2011-01-15 Novartis Vaccines & Diagnostic Polypeptidimpstoffe zum breiten schutz gegen hypervirulente meningokokken-linien
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
US9579372B2 (en) 2008-02-21 2017-02-28 Glaxosmithkline Biologicals Sa Meningococcal fHBP polypeptides
EP2631245A1 (en) 2008-03-10 2013-08-28 Children's Hospital & Research Center at Oakland Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use
HRP20201076T1 (hr) 2009-03-24 2020-10-30 Glaxosmithkline Biologicals Sa Adjuvantni vezujući protein meningokokalnog faktora h
WO2010127172A2 (en) 2009-04-30 2010-11-04 Children's Hospital & Research Center At Oakland Chimeric factor h binding proteins (fhbp) and methods of use
AU2010310985B2 (en) * 2009-10-27 2014-11-06 Glaxosmithkline Biologicals S.A. Modified meningococcal fHBP polypeptides
US9567377B2 (en) * 2010-03-10 2017-02-14 Glaxosmithkline Biologicals Sa Immunogenic composition
ES2661569T3 (es) 2010-03-30 2018-04-02 Children's Hospital & Research Center At Oakland Proteínas de unión al factor H (fHbp) con propiedades alteradas y métodos de uso de las mismas
US10478483B2 (en) 2010-06-25 2019-11-19 Glaxosmithkline Biologicals Sa Combinations of meningococcal factor H binding proteins
ES2654613T3 (es) 2012-02-02 2018-02-14 Glaxosmithkline Biologicals Sa Promotores para una expresión aumentada de proteínas en meningococos
CN104602704B (zh) 2012-06-14 2019-08-06 诺华股份有限公司 针对血清组x脑膜炎球菌的疫苗
AU2013295242C1 (en) 2012-07-27 2018-08-09 Institut National De La Sante Et De La Recherche Medicale CD147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
US20160030544A1 (en) * 2013-03-14 2016-02-04 Isis Innovation Limited Immunogenic composition to neisseria
JP2016527278A (ja) 2013-08-02 2016-09-08 チルドレンズ ホスピタル アンド リサーチ センター オークランド 天然に生じないｈ因子結合タンパク質（ｆｈｂｐ）及びその使用の方法
SG10201907875TA (en) 2014-02-28 2019-09-27 Glaxosmithkline Biologicals Sa Modified meningococcal fhbp polypeptides
ES2922554T3 (es) 2014-07-23 2022-09-16 Childrens Hospital & Res Center At Oakland Variantes de proteínas de unión al factor H y métodos de uso de las mismas
EP3183266B1 (en) * 2014-08-20 2019-05-29 Stichting Sanquin Bloedvoorziening Factor h potentiating antibodies and uses thereof
GB201614687D0 (en) * 2016-08-31 2016-10-12 Univ Oxford Innovation Ltd fHbp scaffold
EP3607967A1 (en) 2018-08-09 2020-02-12 GlaxoSmithKline Biologicals S.A. Modified meningococcal fhbp polypeptides
BR112021012250A2 (pt) 2018-12-21 2021-09-08 Griffith University Composições, métodos e usos para induzir uma resposta imune
EP3997108A4 (en) * 2019-07-08 2024-03-20 Crapaud Bio, Inc. METHODS OF PRODUCING AND USING LIPOOLIGOSACCHARIDE COMPOSITIONS AND VACCINES
EP3999073A4 (en) 2019-07-17 2023-07-26 Gemini Therapeutics Sub, Inc. Factor h potentiating antibodies and uses thereof
TW202245836A (zh) 2021-02-19 2022-12-01 美商賽諾菲巴斯德公司 重組ｂ型腦膜炎球菌疫苗
TW202423477A (zh) 2022-08-03 2024-06-16 美商賽諾菲巴斯德公司 針對腦膜炎奈瑟氏菌b的含佐劑免疫原性組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786592A (en) * 1986-06-18 1988-11-22 Scripps Clinic And Research Foundation Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin
US5476784A (en) * 1993-04-06 1995-12-19 Rice; Peter A. Gonococcal anti-idiotypic antibodies and methods and compositions using them
GB0220194D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
MXPA05011110A (es) * 2003-04-16 2006-01-24 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de un padecimiento originado por meningococos.
MX2007008785A (es) * 2005-01-27 2008-02-15 Childrens Hosp & Res Ct Oak Vacunas de vesicula basadas en gna1870 para proteccion de amplio espectro contra padecimientos causados por neisseria meningitidis.
GB0524066D0 (en) * 2005-11-25 2006-01-04 Chiron Srl 741 ii
AU2007263531B2 (en) * 2006-06-29 2012-03-15 J. Craig Venter Institute, Inc. Polypeptides from neisseria meningitidis
NZ622048A (en) * 2009-08-27 2015-10-30 Novartis Ag Hybrid polypeptides including meningococcal fhbp sequences
ES2661569T3 (es) * 2010-03-30 2018-04-02 Children's Hospital & Research Center At Oakland Proteínas de unión al factor H (fHbp) con propiedades alteradas y métodos de uso de las mismas

Also Published As

Publication number Publication date
AU2009306114A1 (en) 2010-04-29
PL3501534T3 (pl) 2024-04-02
JP2012506411A (ja) 2012-03-15
BRPI0919926A2 (pt) 2016-02-16
US20120052092A1 (en) 2012-03-01
JP2015063558A (ja) 2015-04-09
JP5676458B2 (ja) 2015-02-25
CN102245202A (zh) 2011-11-16
CN105412920A (zh) 2016-03-23
FI3501534T3 (fi) 2024-02-09
EP3501534B1 (en) 2023-11-29
KR20110092282A (ko) 2011-08-17
AU2009306114B2 (en) 2015-10-01
HUE065348T2 (hu) 2024-05-28
EP2355845B1 (en) 2018-12-05
NZ601538A (en) 2014-01-31
MX2011004322A (es) 2011-06-16
EP3501534A1 (en) 2019-06-26
NZ592444A (en) 2012-11-30
JP6076326B2 (ja) 2017-02-08
KR20170000390A (ko) 2017-01-02
EP2355845A1 (en) 2011-08-17
GB0819633D0 (en) 2008-12-03
DK3501534T5 (da) 2024-09-02
WO2010046715A1 (en) 2010-04-29
DK3501534T3 (da) 2024-02-05
CO6382140A2 (es) 2012-02-15
RU2559528C2 (ru) 2015-08-10
SI3501534T1 (sl) 2024-03-29
RU2011120706A (ru) 2012-11-27
ES2970878T3 (es) 2024-05-31
HRP20240226T1 (hr) 2024-05-10
PT3501534T (pt) 2024-02-07
KR20190011836A (ko) 2019-02-07
CA2741619A1 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
HUE065348T2 (hu) Egy mutált H-faktor-kötõ fehérjét tartalmazó vakcinakészítmények
HUE049695T2 (hu) Adjuváló H meningococcus faktort kötõ fehérje
GB2461546B (en) Antigen binding polypeptides
ZA201104397B (en) Myostatin binding proteins
GB2449354B (en) Binding protein
IL219202A0 (en) Il-1 binding proteins
ZA201105177B (en) Il-1 binding proteins
SG10201402960SA (en) IL-17 Binding Proteins
ZA201004133B (en) Antigen binding proteins
IL219048A (en) Peptide compounds derived from urcl10
IL209585A0 (en) Angiopoietin derived peptides
PL2249996T3 (pl) Zszywacz
AU326165S (en) Stapler
EP2252326A4 (en) VACCINE COMPOSITIONS
GB0816976D0 (en) Protein
GB0801122D0 (en) Vaccine composition
PL118319U1 (pl) Zszywacz
AU326017S (en) Stapler
GB0818627D0 (en) Protein
GB0804680D0 (en) Binding polypeptides
GB0714346D0 (en) binding peptides
GB0702363D0 (en) Vaccine composition
IL210002A0 (en) Antigen binding polypeptides
GB0802326D0 (en) Vaccine Composition
GB0817077D0 (en) Proteins